Utilisation of low-dose rivaroxaban in patients with atherosclerotic cardiovascular disease in the united kingdom and the netherlandsFirst published 07/07/2022 Last updated 23/04/2024 EU PAS number: EUPAS48079StudyOngoing
Division of Pharmacoepidemiology & Clinical Pharmacology (PECP), Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht UniversityNetherlands First published: 01/03/2010Last updated 23/05/2024 InstitutionEducational InstitutionENCePP partner